Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hover

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Cancer Research|June 10, 2011
Interleukin-1α mediates the antiproliferative effects of 1,25-dihydroxyvitamin D3 in prostate progenitor/stem cellsSophia L Maund, Wendy W Barclay, Laura D Hover, et al.
Neuro-Oncology|December 20, 2015
Bone morphogenetic protein signaling promotes tumorigenesis in a murine model of high-grade gliomaLaura D Hover, Philip Owens, Alexander L Munden, et al.
Physical Review Letters|July 22, 2015
Thermal and Residual Excited-State Population in a 3D Transmon QubitX Y Jin, A Kamal, A P Sears, et al.
The Journal of Biological Chemistry|November 17, 2024
Impaired branched-chain amino acid (BCAA) catabolism during adipocyte differentiation decreases glycolytic fluxCourtney R Green, Lynn M Alaeddine, Karl A Wessendorf-Rodriguez, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 2019
Defining Optimal Target Volumes of Conformal Radiation Therapy for Diffuse Intrinsic Pontine GliomaChristopher L Tinkle, Brittany Simone, Jason Chiang, et al.
Nature Chemical Biology|October 18, 2018
Enzyme promiscuity drives branched-chain fatty acid synthesis in adipose tissuesMartina Wallace, Courtney R Green, Lindsay S Roberts, et al.
Nature Communications|August 18, 2019
Deep multiomics profiling of brain tumors identifies signaling networks downstream of cancer driver genesHong Wang, Alexander K Diaz, Timothy I Shaw, et al.
Molecular Cancer Therapeutics|June 21, 2024
The SOS1 Inhibitor MRTX0902 Blocks KRAS Activation and Demonstrates Antitumor Activity in Cancers Dependent on KRAS Nucleotide LoadingNiranjan Sudhakar, Larry Yan, Fadia Qiryaqos, et al.
Cancer Discovery|August 8, 2023
MRTX1719 Is an MTA-Cooperative PRMT5 Inhibitor That Exhibits Synthetic Lethality in Preclinical Models and Patients with MTAP-Deleted CancerLars D Engstrom, Ruth Aranda, Laura Waters, et al.
Science (New York, N.Y.)|June 6, 2024
Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancersJeffrey A Klomp, Jennifer E Klomp, Clint A Stalnecker, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Cancer Research|June 10, 2011
Interleukin-1α mediates the antiproliferative effects of 1,25-dihydroxyvitamin D3 in prostate progenitor/stem cellsSophia L Maund, Wendy W Barclay, Laura D Hover, et al.
Neuro-Oncology|December 20, 2015
Bone morphogenetic protein signaling promotes tumorigenesis in a murine model of high-grade gliomaLaura D Hover, Philip Owens, Alexander L Munden, et al.
Physical Review Letters|July 22, 2015
Thermal and Residual Excited-State Population in a 3D Transmon QubitX Y Jin, A Kamal, A P Sears, et al.
The Journal of Biological Chemistry|November 17, 2024
Impaired branched-chain amino acid (BCAA) catabolism during adipocyte differentiation decreases glycolytic fluxCourtney R Green, Lynn M Alaeddine, Karl A Wessendorf-Rodriguez, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 2019
Defining Optimal Target Volumes of Conformal Radiation Therapy for Diffuse Intrinsic Pontine GliomaChristopher L Tinkle, Brittany Simone, Jason Chiang, et al.
Nature Chemical Biology|October 18, 2018
Enzyme promiscuity drives branched-chain fatty acid synthesis in adipose tissuesMartina Wallace, Courtney R Green, Lindsay S Roberts, et al.
Nature Communications|August 18, 2019
Deep multiomics profiling of brain tumors identifies signaling networks downstream of cancer driver genesHong Wang, Alexander K Diaz, Timothy I Shaw, et al.
Molecular Cancer Therapeutics|June 21, 2024
The SOS1 Inhibitor MRTX0902 Blocks KRAS Activation and Demonstrates Antitumor Activity in Cancers Dependent on KRAS Nucleotide LoadingNiranjan Sudhakar, Larry Yan, Fadia Qiryaqos, et al.
Cancer Discovery|August 8, 2023
MRTX1719 Is an MTA-Cooperative PRMT5 Inhibitor That Exhibits Synthetic Lethality in Preclinical Models and Patients with MTAP-Deleted CancerLars D Engstrom, Ruth Aranda, Laura Waters, et al.
Science (New York, N.Y.)|June 6, 2024
Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancersJeffrey A Klomp, Jennifer E Klomp, Clint A Stalnecker, et al.
Pageof 4